RxDoctor Payments Data

Herman Hans, MD

Family Medicine · Tampa, FLNPI 1841788718

Payments from drug & device makers

$3,156in general payments, 2019–2025

Across 126 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$621
  • AstraZeneca$617
  • Lilly USA, LLC$335
  • Exact Sciences$321
  • AbbVie$217
  • Medtronic$187
  • plus $857 from 14 others

What the payments were for

  • Food & beverage$3,156100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,156 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$32,539
Medicare patients
118
Services billed
320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$28,376
JanuviaSitagliptin Phosphate20$23,188
FarxigaDapagliflozin Propanediol15$19,010
LinzessLinaclotide14$8,935
LantusInsulin Glargine,hum.Rec.Anlog11$2,139
Solifenacin Succinate18$2,109
SynthroidLevothyroxine Sodium13$771
Fluticasone Propionate53$657
Famotidine27$638
Atorvastatin Calcium98$611
Omeprazole28$455
Amlodipine Besylate77$425
Losartan Potassium61$412
Pantoprazole Sodium47$410
Gabapentin25$409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$63$23,18820 claims
AstraZenecaFarxiga$617$19,01015 claims
AbbVieLinzess, Synthroid$217$9,70627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →